Structure Therapeutics Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
38.46 |
0.00 |
24.80 |
541.48 |
699.51 |
| Przychód Δ r/r |
0.00% |
inf% |
-100.00% |
inf% |
2083.37% |
29.19% |
| Przychód (min) |
0.00 |
38.46 |
0.00 |
24.80 |
541.48 |
699.51 |
| Przychód (max) |
0.00 |
38.46 |
0.00 |
24.80 |
541.48 |
699.51 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-46.08 |
-44.10 |
-144.68 |
-91.40 |
-92.86 |
-3.16 |
| Zysk netto % |
-inf% |
-114.66% |
-inf% |
-368.55% |
-17.15% |
-0.45% |
| EPS (średnia) |
-0.81 |
-0.84 |
-1.50 |
-1.68 |
-1.76 |
-0.06 |
| Liczba analityków (Przychody) |
0 |
7 |
0 |
9 |
3 |
4 |
| Liczba analityków (EPS) |
8 |
9 |
8 |
6 |
3 |
4 |
| symbol |
GPCR |
GPCR |
GPCR |
GPCR |
GPCR |
GPCR |